Search
for
Sort by
Research 271–300 of 1000+
- Green formulation of spironolactone loaded chitosan coated nano lipid carrier for treatment of acne vulgaris: a randomized double-blind clinical trial
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Polycystic ovary syndrome
- Obesity and the skin: Skin physiology and skin manifestations of obesity
- Visually scoring hirsutism
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Health and fertility in World Health Organization group 2 anovulatory women
- Polycystic Ovary Syndrome
- Dermatologic manifestations of endocrine disorders
- Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
- Acne and Systemic Disease
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Insulin Resistance and Skin Diseases
- A case series of 20 women with hidradenitis suppurativa treated with spironolactone
- Microneedle-Based Approaches for Skin Disease Treatment
- Hormonal treatment of acne vulgaris: an update
- Evidence-based approach to cutaneous hyperandrogenism in women
- Polycystic Ovary Syndrome and Its Differential Diagnosis
- Oxidative stress management in the hair follicle: Could targeting NRF2 counter age‐related hair disorders and beyond?
- Changes of androgens levels in menopausal women
- Guidelines for the Use of Acitretin in Psoriasis
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Hirsutism, postpartum telogen effluvium, and male pattern alopecia
- Targets to treat androgen excess in polycystic ovary syndrome
- Exploring the Multifaceted Impact of Acne on Quality of Life and Well-Being
- COVID-19 infection leading to acute pustular dermatoses